Indications and uses
Temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: • runny nose • sneezing • itchy, watery eyes • itching of the nose or throat
Temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: • runny nose • sneezing • itchy, watery eyes • itching of the nose or throat
• may be taken with or without water • chew or crush tablets completely before swallowing adults and children 6 years and over 1 to 2 tablets once daily; depending upon severity of symptoms; do not take more than 2 tablets in 24 hours adults 65 years and over 1 tablet once a day; do not take more than 1 tablet in 24 hours children under 6 years of age ask a doctor consumers with liver or kidney disease ask a docto...
(in each chewable tablet)
Cetirizine HCl 5 mg
Antihistamine
Temporarily relieves these symptoms due to hay fever or other upper respiratory allergies:
Do not use if you have ever had an allergic reaction to this product or any of its ingredients or to an antihistamine containing hydroxyzine.
Ask a doctor before use if you have liver or kidney disease. Your doctor should determine if you need a different dose.
Ask a doctor or pharmacist before use if you are taking tranquilizers or sedatives.
When using this product
Stop use and ask a doctor if an allergic reaction to this product occurs. Seek medical help right away.
If pregnant or breast-feeding:
In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).
adults and children 6 years and over | 1 to 2 tablets once daily; depending upon severity of symptoms; do not take more than 2 tablets in 24 hours |
adults 65 years and over | 1 tablet once a day; do not take more than 1 tablet in 24 hours |
children under 6 years of age | ask a doctor |
consumers with liver or kidney disease | ask a doctor |
Store between 20ºC to 25º C (68ºF to 77º F)
acesulfame potassium, artificial flavors, benzyl alcohol, betadex, colloidal silicon dioxide, dl-alpha-tocopherol, ferric oxide red, ferric oxide yellow, lactose monohydrate, magnesium stearate, maltodextrin, microcrystalline cellulose, propylene glycol, talc and tutti frutti flavor.
Questions? 1-800-525-8747
Manufactured by
Sandoz Private Limited, India
for Sandoz Inc., Princeton, NJ 08540
Product of India
Revised: 04/2026
NDC 0781-5283-64
Children's
Cetirizine HCl Chewable Tablets
5 mg
antihistamine
Tutti Frutti Flavored
30 Chewable Tablets
Do not use if individual blister unit is open or torn
ALLERGY
Indoor & Outdoor Allergies
6 years and older
5 mg each
24 hour Relief of
Chew or crush tablets completely before swallowing

| Class | Version | Type | Effective |
|---|---|---|---|
| CETIRIZINE Pharmacologic Class Indexing | 3 | Indexing - Pharmacologic Class | 20180813 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| c505bb17-4ff9-45f9-ac2d-bb9c8c9d35be | Product name | 1 | 20200304 |
| a255659f-db40-429d-8c07-5f173f330d9c | Product name | 1 | 20190402 |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0781-5283-06 | EA - Each | 0781-5283 | 9597b375-16fa-45e7-bd32-2b8a665b5ed3 | 1 | 2018-11-06 |
| 0781-5283-64 | EA - Each | 0781-5283 | 769a8519-0fc0-46fb-9d34-27d6048503bb | 1 | 2012-07-24 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| CETIRIZINE HYDROCHLORIDE | ACTIVE INGREDIENT | 64O047KTOA | 2 | |
| CETIRIZINE | ACTIVE MOIETY | YO7261ME24 | 2 | |
| .ALPHA.-TOCOPHEROL ACETATE, DL- | INACTIVE INGREDIENT | WR1WPI7EW8 | 2 | |
| ACESULFAME POTASSIUM | INACTIVE INGREDIENT | 23OV73Q5G9 | 2 | |
| BENZYL ALCOHOL | INACTIVE INGREDIENT | LKG8494WBH | 2 | |
| BETADEX | INACTIVE INGREDIENT | JV039JZZ3A | 2 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | 2 | |
| FERRIC OXIDE RED | INACTIVE INGREDIENT | 1K09F3G675 | 2 | |
| FERRIC OXIDE YELLOW | INACTIVE INGREDIENT | EX438O2MRT | 2 | |
| LACTOSE MONOHYDRATE | INACTIVE INGREDIENT | EWQ57Q8I5X | 2 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | 2 | |
| MALTODEXTRIN | INACTIVE INGREDIENT | 7CVR7L4A2D | 2 | |
| PROPYLENE GLYCOL | INACTIVE INGREDIENT | 6DC9Q167V3 | 2 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | 2 | |
| TALC | INACTIVE INGREDIENT | 7SEV7J4R1U | 2 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 0781-5283 | 0781-5283-06, 0781-5283-64 |
Every source-derived ingredient row is available through these pages.
| Version | Effective date | Source | Hydrated |
|---|---|---|---|
| 7 | 2024-10-09 | full-release | 2026-06-01 00:54:08 |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | CAPSULE / ORAL | 1072 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SOLUTION, CONCENTRATE / ORAL | 2590 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SOLUTION / ORAL | 22602 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | CAPSULE, COATED / ORAL | 25 mg | ||
| BENZYL ALCOHOL | BENZYL ALCOHOL | LKG8494WBH | TABLET / ORAL | 1.06 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | TABLET, EXTENDED RELEASE / ORAL | 9 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | TABLET, COATED / ORAL | 16 mg | ||
| BENZYL ALCOHOL | BENZYL ALCOHOL | LKG8494WBH | CAPSULE, EXTENDED RELEASE / ORAL | 1.23 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | TABLET, DELAYED RELEASE / ORAL | 36 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | CAPSULE, COATED, EXTENDED RELEASE / ORAL | NA | ||
| LACTOSE MONOHYDRATE | LACTOSE MONOHYDRATE | EWQ57Q8I5X | TABLET, CHEWABLE / ORAL | 1412 mg | ||
| BENZYL ALCOHOL | BENZYL ALCOHOL | LKG8494WBH | SUSPENSION / ORAL | 100 mg | ||
| FERRIC OXIDE YELLOW | FERRIC OXIDE YELLOW | EX438O2MRT | TABLET, CHEWABLE / ORAL | 14 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | TABLET, FILM COATED / ORAL | 96 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | CAPSULE, EXTENDED RELEASE / ORAL | 8 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | CAPSULE, EXTENDED RELEASE / ORAL | 8 mg | ||
| .ALPHA.-TOCOPHEROL ACETATE, DL- | .ALPHA.-TOCOPHEROL ACETATE, DL- | WR1WPI7EW8 | OINTMENT / TOPICAL | NA | ||
| TALC | TALC | 7SEV7J4R1U | TABLET, CHEWABLE / ORAL | 202 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, CHEWABLE / ORAL | 127 mg | ||
| ACESULFAME POTASSIUM | ACESULFAME POTASSIUM | 23OV73Q5G9 | TABLET, CHEWABLE / ORAL | 15 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | CONCENTRATE / ORAL | 7000 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | CAPSULE, COATED / ORAL | 25 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, CHEWABLE / ORAL | 254 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | ELIXIR / ORAL | 9306 mg | ||
| MALTODEXTRIN | MALTODEXTRIN | 7CVR7L4A2D | TABLET, CHEWABLE / ORAL | 292 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, CHEWABLE / ORAL | 127 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SUSPENSION, EXTENDED RELEASE / ORAL | 1000 mg | ||
| .ALPHA.-TOCOPHEROL ACETATE, DL- | .ALPHA.-TOCOPHEROL ACETATE, DL- | WR1WPI7EW8 | OINTMENT / TOPICAL | NA | ||
| LACTOSE MONOHYDRATE | LACTOSE MONOHYDRATE | EWQ57Q8I5X | TABLET, CHEWABLE / ORAL | 1412 mg | ||
| BENZYL ALCOHOL | BENZYL ALCOHOL | LKG8494WBH | CAPSULE / ORAL | 450 mg | ||
| BENZYL ALCOHOL | BENZYL ALCOHOL | LKG8494WBH | CAPSULE / ORAL | 450 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, CHEWABLE / ORAL | 254 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | CONCENTRATE / ORAL | 7000 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SYRUP / ORAL | 5700 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, CHEWABLE / ORAL | 1725 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | TABLET, EXTENDED RELEASE / ORAL | 9 mg | ||
| BENZYL ALCOHOL | BENZYL ALCOHOL | LKG8494WBH | TABLET, DELAYED RELEASE / ORAL | 2.31 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | CAPSULE, COATED, EXTENDED RELEASE / ORAL | NA | ||
| FERRIC OXIDE YELLOW | FERRIC OXIDE YELLOW | EX438O2MRT | TABLET, CHEWABLE / ORAL | 14 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 19 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | TABLET, DELAYED RELEASE / ORAL | 36 mg | ||
| BENZYL ALCOHOL | BENZYL ALCOHOL | LKG8494WBH | SOLUTION / ORAL | 360 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | CAPSULE, EXTENDED RELEASE / ORAL | 8 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SUSPENSION / ORAL | 27120 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | CAPSULE, DELAYED RELEASE / ORAL | 1.7 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | ELIXIR / ORAL | 9306 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | TABLET, DELAYED RELEASE / ORAL | 36 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET, CHEWABLE / ORAL | 202 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | LIQUID / ORAL | 29008 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SUSPENSION / ORAL | 27120 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | DROPS / ORAL | 200 mg/1ml | ||
| TALC | TALC | 7SEV7J4R1U | TABLET, CHEWABLE / ORAL | 202 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | CAPSULE, COATED / ORAL | 25 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | CAPSULE / ORAL | 1072 mg | ||
| BETADEX | BETADEX | JV039JZZ3A | TABLET, CHEWABLE / ORAL | 85 mg | ||
| BENZYL ALCOHOL | BENZYL ALCOHOL | LKG8494WBH | SUSPENSION / ORAL | 100 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | TABLET, COATED / ORAL | 16 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | DROPS / ORAL | 200 mg/1ml | ||
| BENZYL ALCOHOL | BENZYL ALCOHOL | LKG8494WBH | SOLUTION / ORAL | 360 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, CHEWABLE / ORAL | 1725 mg |
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A078692-001 | CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY | CETIRIZINE HYDROCHLORIDE | 5MG | TABLET, CHEWABLE / ORAL | 2008-02-14 | ||
| A078692-002 | CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY | CETIRIZINE HYDROCHLORIDE | 10MG | TABLET, CHEWABLE / ORAL | RS | 2008-02-14 |
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A078692-001 | CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY | 5MG | TABLET, CHEWABLE / ORAL | 2008-02-14 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A078692-002 | CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY | 10MG | TABLET, CHEWABLE / ORAL | RS | 2008-02-14 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A078692-001 | CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY | 5MG | TABLET, CHEWABLE / ORAL | 2008-02-14 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A078692-002 | CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY | 10MG | TABLET, CHEWABLE / ORAL | RS | 2008-02-14 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A078692-001 | CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY | 5MG | TABLET, CHEWABLE / ORAL | 2008-02-14 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A078692-002 | CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY | 10MG | TABLET, CHEWABLE / ORAL | RS | 2008-02-14 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A078692-001 | CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY | 5MG | TABLET, CHEWABLE / ORAL | 2008-02-14 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A078692-002 | CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY | 10MG | TABLET, CHEWABLE / ORAL | RS | 2008-02-14 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A078692-001 | CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY | 5MG | TABLET, CHEWABLE / ORAL | 2008-02-14 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A078692-002 | CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY | 10MG | TABLET, CHEWABLE / ORAL | RS | 2008-02-14 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A078692-001 | CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY | 5MG | TABLET, CHEWABLE / ORAL | 2008-02-14 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A078692-002 | CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY | 10MG | TABLET, CHEWABLE / ORAL | RS | 2008-02-14 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A078692-001 | CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY | 5MG | TABLET, CHEWABLE / ORAL | 2008-02-14 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A078692-002 | CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY | 10MG | TABLET, CHEWABLE / ORAL | RS | 2008-02-14 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A078692-001 | CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY | 5MG | TABLET, CHEWABLE / ORAL | 2008-02-14 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A078692-002 | CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY | 10MG | TABLET, CHEWABLE / ORAL | RS | 2008-02-14 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A078692-001 | CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY | 5MG | TABLET, CHEWABLE / ORAL | 2008-02-14 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A078692-002 | CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY | 10MG | TABLET, CHEWABLE / ORAL | RS | 2008-02-14 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A078692-001 | CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY | 5MG | TABLET, CHEWABLE / ORAL | 2008-02-14 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A078692-002 | CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY | 10MG | TABLET, CHEWABLE / ORAL | RS | 2008-02-14 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A078692-001 | CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY | 5MG | TABLET, CHEWABLE / ORAL | 2008-02-14 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A078692-002 | CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY | 10MG | TABLET, CHEWABLE / ORAL | RS | 2008-02-14 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A078692-001 | CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY | 5MG | TABLET, CHEWABLE / ORAL | 2008-02-14 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A078692-002 | CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY | 10MG | TABLET, CHEWABLE / ORAL | RS | 2008-02-14 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A078692-001 | CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY | 5MG | TABLET, CHEWABLE / ORAL | 2008-02-14 | 79d66fd596c7… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A078692-002 | CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY | 10MG | TABLET, CHEWABLE / ORAL | RS | 2008-02-14 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A078692-001 | CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY | 5MG | TABLET, CHEWABLE / ORAL | 2008-02-14 | 301d65b070ca… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A078692-002 | CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY | 10MG | TABLET, CHEWABLE / ORAL | RS | 2008-02-14 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A078692-001 | CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY | 5MG | TABLET, CHEWABLE / ORAL | 2008-02-14 | 1e350fbaab3a… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A078692-002 | CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY | 10MG | TABLET, CHEWABLE / ORAL | RS | 2008-02-14 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | A078692-001 | CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY | 5MG | TABLET, CHEWABLE / ORAL | 2008-02-14 | 8072bd15b7f6… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A078692-002 | CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY | 10MG | TABLET, CHEWABLE / ORAL | RS | 2008-02-14 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A078692-001 | CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY | 5MG | TABLET, CHEWABLE / ORAL | 2008-02-14 | 5c6f7cd8ea54… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A078692-002 | CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY | 10MG | TABLET, CHEWABLE / ORAL | RS | 2008-02-14 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | A078692-001 | CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY | 5MG | TABLET, CHEWABLE / ORAL | 2008-02-14 | 5d02ea3f76ae… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A078692-002 | CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY | 10MG | TABLET, CHEWABLE / ORAL | RS | 2008-02-14 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | A078692-001 | CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY | 5MG | TABLET, CHEWABLE / ORAL | 2008-02-14 | 4b0b4de00fa7… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A078692-002 | CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY | 10MG | TABLET, CHEWABLE / ORAL | RS | 2008-02-14 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | A078692-001 | CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY | 5MG | TABLET, CHEWABLE / ORAL | 2008-02-14 | 74a2ff9319b5… | ||
| 2019-12-13 00:20 UTC | 2019-12 | A078692-002 | CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY | 10MG | TABLET, CHEWABLE / ORAL | RS | 2008-02-14 | 74a2ff9319b5… |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Cetirizine Hydrochloride | CETIRIZINE HYDROCHLORIDE | Sandoz Inc | 817d07cf-5e31-421f-9e95-943bae01f5b0 | 2025-06-30 | Warnings | 0781-5283-64 0781-5283-06 0781-5283 00781528306 00781528364 73150a55-d6f0-4ae0-847a-f9679694bf80 817d07cf-5e31-421f-9e95-943bae01f5b0 |
Adverse event summaries are temporarily unavailable. Other product information remains available.